GlassScriptPhysician profile
Matthew S Bernard
NPI 1164632626
$135,927.70
in general payments reported to CMS, 2019-2025
39 companies · $26K in 2025
The $26K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $1,615 · 2021: $15K · 2022: $1,860 · 2023: $57K · 2024: $34K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $85K · Travel and Lodging: $21K · Consulting Fee: $7,050 · Food and Beverage: $4,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $84,668.00 |
| Travel and Lodging | $20,823.71 |
| Consulting Fee | $7,050.00 |
| Food and Beverage | $4,743.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $116,380.16 | 2021-2025 | Iovera, Exparel, Zilretta |
| Smith+Nephew, INC. | $15,456.26 | 2019-2025 | Journey II, Redapt, Real Intelligence |
| Heron Therapeutics, INC. | $1,669.13 | 2020-2024 | Zynrelef, Aponvie |
| Medtronic, INC. | $361.45 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Plasmablade(Tm) |
| Intrinsic Therapeutics | $299.34 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Stryker Corporation | $287.29 | 2021-2024 | Tritanium |
| Corin USA | $267.47 | 2019 | |
| Linvatec Corporation | $173.27 | 2023 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $123.87 | 2025 | |
| Djo, LLC | $116.63 | 2021-2025 | Cmf |
| Omnilife Science, INC | $104.01 | 2020-2021 | |
| Boston Scientific Corporation | $61.53 | 2023 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $49.00 | 2024 | Nalu Neurostimulation System |
| Kowa Pharmaceuticals America, INC. | $45.91 | 2022-2023 | Seglentis |
| Fidia Pharma USA INC. | $43.29 | 2021-2023 | Hymovis, Triluron |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $36.75 | 2022 | |
| Nusmile, LTD. | $35.67 | 2020 | |
| Ethicon US, LLC | $31.81 | 2021-2023 | Megadyne |
| Davol INC. | $30.82 | 2022 | |
| Abbvie INC. | $29.33 | 2022-2023 | Dalvance |
| Kci USA, INC. | $27.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.07 | 2025 | Wainua |
| Convatec INC. | $24.25 | 2024 | |
| Pacira Therapeutics, INC. | $23.13 | 2021 | |
| Solventum Corporation | $21.32 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Horizon Therapeutics Plc | $17.72 | 2021 | |
| Painteq LLC | $17.27 | 2024 | Painteq |
| Medacta USA, INC. | $17.04 | 2022 | |
| Orthogenrx INC. | $17.02 | 2021 | |
| Spinal Simplicity, LLC | $15.63 | 2022 | |
| Endo USA, INC. | $14.72 | 2025 | Xiaflex |
| Bioventus LLC | $14.19 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $14.18 | 2025 | |
| Radius Health, INC. | $13.75 | 2021 | |
| Sanara Medtech INC. | $13.58 | 2021 | |
| Curonix LLC | $13.43 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $12.61 | 2021 | |
| Abbott Laboratories | $12.10 | 2022 | |
| Orthofix Medical, INC. | $9.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.